An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study

AstraZeneca

Status: Completed

Conditions: Acute Coronary Syndromes

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01061086

NIS-CGR-DUM-2009/1

Details and patient eligibility

About

This is a multicenter, 2-phase observational study of acute coronary syndromes (ACS) in Greece, designed to provide real world data on the risk factors of patients presenting to a hospital emergency department with an index event, as well as to depict the current management practices and outcomes of these clinical conditions in Greece.

Enrollment: 418 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of an ACS (STEMI, NSTEMI, UA).
• Informed Consent

Exclusion criteria

• Involvement in the planning and conduct of the study (applies to both AstraZeneca staff and staff at the study sites).
• Participation in other clinical study in period between the index event and 6- month follow-up assessment with the exception of registering in registries or surveys not influencing the management of the ACS.

Trial design

418 participants in 1 patient group

1

Description:

Patients over 18 years old admitted to the hospital with Acute Coronary Syndrome.